AAO News
The latest clinical breakthroughs, practice management updates, and national advocacy alerts directly from the American Academy of Ophthalmology.
To investigate changes in subfoveal choroidal thickness after intravitreal aflibercept injections (IAIs) for neovascular age-related macular degeneration (AMD) at 12 months.
To evaluate the feasibility and outcomes of contact lens-assisted bimanual pull-through delivery of Descemet membrane endothelial keratoplasty (DMEK) tissue trifolded with the endothelium inward.
Numerous epidemiologic studies have evaluated the association of statin use and cataracts but the results have been inconsistent.1–3 Statins, or 3-hydroxy-3methylglutaryl-coenzyme A reductase inhibitors, are currently the most common lipid-lowering class of drugs. The Age-Related Eye Diseases Study 2 (AREDS2) was a prospective, multicenter, clinical trial that evaluated the progression of age-related macular degeneration (AMD) and cataract in participants aged 50 to 85 with at least intermediate AMD.
The objective of this study was to compare the cost associated with surgical versus interferon-alpha 2b (IFNα2b) treatment for ocular surface squamous neoplasia (OSSN).
To evaluate the adjuvant role of amniotic membrane transplantation (AMT) in cases of acute ocular Stevens–Johnson syndrome (SJS).
Cellceutix Corporation announced that the U.S. FDA granted rare pediatric disease designation to kevetrin for the treatment of retinoblastoma.
Our Industry Partners
Empowering Excellence in Ophthalmology
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.
West Virginia Academy of Eye Physicians and Surgeons — advancing quality eye care through education, advocacy, and community awareness.
About
Resources
Advocacy